Impact of Vaccination in Patients with MPS VI Vaccination in patients with mucopolysaccharidosis VI (MPS VI) plays a crucial role in preventing infections that can further complicate the condition of these individuals. These patients, due to their compromised immune system and multiple associated comorbidities, are especially vulnerable to respiratory infections and other vaccine-preventable diseases. Therefore, […]